Clinical Trial Update: Second-line Surufatinib Combined With Chemotherapy in Advanced CRC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating surufatinib combined with chemotherapy as second-line treatment for advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: UNKNOWN